All comparisons
BPC-157 vs TB-500 (Thymosin Beta-4)
Comparing self-reported PepTalk data: BPC-157 does not have enough reports yet to show a cohort figure (n=0), while TB-500 (Thymosin Beta-4) does not have enough reports yet to show a cohort figure (n=0).
BPC-157
Healing & Recovery Peptides
Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects
Not enough data yet.
TB-500 (Thymosin Beta-4)
Healing & Recovery Peptides
Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects
Not enough data yet.
Self-reported by users, unverified. Not medical advice and not an endorsement of any substance. 18+ only.